1. Home
  2. USNA vs HELP Comparison

USNA vs HELP Comparison

Compare USNA & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo USANA Health Sciences Inc.

USNA

USANA Health Sciences Inc.

HOLD

Current Price

$20.11

Market Cap

382.1M

Sector

Health Care

ML Signal

HOLD

HELP

Cybin Inc. Common Stock

N/A

Current Price

$7.66

Market Cap

366.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
USNA
HELP
Founded
1992
N/A
Country
United States
Canada
Employees
N/A
50
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
382.1M
366.7M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
USNA
HELP
Price
$20.11
$7.66
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$36.00
N/A
AVG Volume (30 Days)
107.2K
591.7K
Earning Date
05-18-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.67
N/A
Revenue
$1,060,902,000.00
N/A
Revenue This Year
$5.41
N/A
Revenue Next Year
$6.12
N/A
P/E Ratio
$32.12
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.48
$5.76
52 Week High
$38.32
$8.23

Technical Indicators

Market Signals
Indicator
USNA
HELP
Relative Strength Index (RSI) 42.28 58.71
Support Level $18.98 $7.33
Resistance Level $22.03 $8.23
Average True Range (ATR) 1.17 0.62
MACD -0.05 0.16
Stochastic Oscillator 36.08 89.74

Price Performance

Historical Comparison
USNA
HELP

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.

About HELP Cybin Inc. Common Stock

Helus Pharma Inc is a clinical-stage pharmaceutical company developing proprietary novel serotonergic agonists (NSAs), which are synthetic molecules designed to activate serotonin pathways associated with neuroplasticity. These compounds are being investigated for potential use in the treatment of depression, anxiety, and other mental health conditions, areas where there is an unmet medical need. It aims to provide treatments designed for mental health disorders. The company is currently developing HLP003, a proprietary NSA, in Phase 3 clinical development for the adjunctive treatment of substantial depressive disorder. It operates in Canada, the United States, the United Kingdom, and Ireland.

Share on Social Networks: